Intuitive Surgical, Inc. (ISRG)
NASDAQ: ISRG · Real-Time Price · USD
575.34
+6.71 (1.18%)
At close: Dec 5, 2025, 4:00 PM EST
575.67
+0.33 (0.06%)
After-hours: Dec 5, 2025, 7:59 PM EST
Intuitive Surgical Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Intuitive Surgical stock have an average target of 591.57, with a low estimate of 440 and a high estimate of 675. The average target predicts an increase of 2.82% from the current stock price of 575.34.
Analyst Consensus: Buy
* Price targets were last updated on Oct 23, 2025.
Analyst Ratings
The average analyst rating for Intuitive Surgical stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 5 | 5 | 5 | 4 |
| Buy | 8 | 8 | 8 | 8 | 8 | 7 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 17 | 16 | 16 | 16 | 16 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $585 → $600 | Hold | Maintains | $585 → $600 | +4.29% | Oct 23, 2025 |
| Raymond James | Raymond James | Buy Maintains $592 → $603 | Buy | Maintains | $592 → $603 | +4.81% | Oct 22, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $595 → $610 | Buy | Reiterates | $595 → $610 | +6.02% | Oct 22, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $615 → $625 | Buy | Maintains | $615 → $625 | +8.63% | Oct 22, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $525 → $620 | Strong Buy | Maintains | $525 → $620 | +7.76% | Oct 22, 2025 |
Financial Forecast
Revenue This Year
10.12B
from 8.35B
Increased by 21.14%
Revenue Next Year
11.63B
from 10.12B
Increased by 14.94%
EPS This Year
8.80
from 6.42
Increased by 37.15%
EPS Next Year
9.92
from 8.80
Increased by 12.63%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 10.6B | 13.0B | ||||
| Avg | 10.1B | 11.6B | ||||
| Low | 9.6B | 10.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 26.8% | 28.7% | ||||
| Avg | 21.1% | 14.9% | ||||
| Low | 14.5% | 7.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 9.19 | 11.79 | ||||
| Avg | 8.80 | 9.92 | ||||
| Low | 8.18 | 8.75 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 43.1% | 33.9% | ||||
| Avg | 37.1% | 12.6% | ||||
| Low | 27.5% | -0.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.